SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009044
Filing Date
2015-11-02
Accepted
2015-11-02 07:30:45
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q thld-10q_20150930.htm 10-Q 1541148
2 EX-10.1 thld-ex101_484.htm EX-10.1 236440
3 EX-31.1 thld-ex311_6.htm EX-31.1 13990
4 EX-31.2 thld-ex312_8.htm EX-31.2 14014
5 EX-32.1 thld-ex321_10.htm EX-32.1 5908
6 EX-32.2 thld-ex322_7.htm EX-32.2 5985
  Complete submission text file 0001564590-15-009044.txt   6531650

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thld-20150930.xml EX-101.INS 1682975
8 XBRL TAXONOMY EXTENSION SCHEMA thld-20150930.xsd EX-101.SCH 30291
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20150930_cal.xml EX-101.CAL 37343
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20150930_def.xml EX-101.DEF 108709
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20150930_lab.xml EX-101.LAB 273757
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20150930_pre.xml EX-101.PRE 220952
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 151189195
SIC: 2834 Pharmaceutical Preparations